IL17A and autoimmune disease: It has been reported that IL-17 and Th17 cells are highly up-regulated in inflammatory tissues of autoimmune diseases, suggesting the ratio of Th17 cells can be used as a parameter to monitor the irAEs of checkpoint inhibitor immunotherapy19,20.